Functional status of hospitalized pediatric patients with COVID-19 in southern Brazil: a prospective cohort study

Giovana Morin Casassola1, Caroline Jacoby Schmidt1, Guilherme Hoff Affeldt2

  • 1. Hospital de Clínicas de Porto Alegre, Porto Alegre (RS), Brasil.

Insights

Over half of children hospitalized with COVID-19 experienced functional changes. Pre-existing conditions and need for respiratory support worsened functional status and prolonged hospital stays in pediatric COVID-19 patients.

Area of Science:

  • Pediatric Medicine
  • Infectious Diseases
  • Rehabilitation Medicine

Background:

  • COVID-19 significantly impacts pediatric populations, necessitating an understanding of its effects on children's functional status.
  • Assessing functional status is crucial for managing long-term outcomes and recovery in pediatric patients post-COVID-19 hospitalization.

Purpose of the Study:

  • To evaluate the functional status of children hospitalized with COVID-19.
  • To identify associations between functional status and clinical features in pediatric COVID-19 patients.

Main Methods:

  • A prospective cohort study involving 62 children diagnosed with COVID-19 admitted to a tertiary hospital.
  • Functional status was assessed using the pediatric Functional Status Scale (FSS).
  • Statistical analyses, including multivariate analysis, were performed to determine associations.

Main Results:

  • Approximately 55% of hospitalized children exhibited some degree of functional alteration.
  • Higher FSS scores correlated with longer hospital stays, increased need for oxygen therapy, mechanical ventilation, and intensive care unit admissions.
  • Significant associations were found between functional status, comorbidities, and length of stay.

Conclusions:

  • More than half of pediatric COVID-19 patients hospitalized experienced functional changes.
  • Functional status alterations were linked to pre-existing comorbidities, increased need for ventilatory support, and extended hospitalizations.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
413
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
340
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
277
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
180
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
258